Bär & Karrer Advises HAS on its Strategic Acquisition of Cerbios-Pharma

HAS Healthcare Advanced Synthesis SA, backed by 65 Equity Partners, is acquiring Chemholding due SA and its subsidiaries, including its main operative company Cerbios-Pharma SA, thereby establishing a highly complementary and integrated leader in the contract development and manufacturing organization (CDMO) industry. The completion of the transaction is subject to certain conditions.

Bär & Karrer acts as legal advisor to HAS Healthcare Advanced Synthesis SA and its sole shareholder in this transaction. The team is co-led by Paolo Bottini (Tax and M&A), Andrea Ziswiler (Corporate and M&A) and Rocco Rigozzi (Corporate and Real Estate). It includes Bryan Bruschi and Franco Singenberger (both Corporate and Employment), Susanne Schreiber and Aron Liechti (both Tax), Markus Schott and Julia Stempfel (both Healthcare & Life Sciences), Jonas Bornhauser (IP/IT and Data Protection), Mani Reinert and Tim Meyer (Competition Law) as well as Ruth Bloch-Riemer and Sébastien Di Natale (both Pension & Social Security). Vinge (Sweden) and E+H Attorneys-at-Law (Austria) assist Bär & Karrer with respect to certain Swedish and Austrian matters, respectively.